UA6823U - Method for treating acute experimental pancreatitis - Google Patents
Method for treating acute experimental pancreatitisInfo
- Publication number
- UA6823U UA6823U UA20041209835U UA20041209835U UA6823U UA 6823 U UA6823 U UA 6823U UA 20041209835 U UA20041209835 U UA 20041209835U UA 20041209835 U UA20041209835 U UA 20041209835U UA 6823 U UA6823 U UA 6823U
- Authority
- UA
- Ukraine
- Prior art keywords
- treating acute
- acute experimental
- experimental pancreatitis
- pancreatitis
- treating
- Prior art date
Links
- 206010033645 Pancreatitis Diseases 0.000 title abstract 2
- 230000001154 acute effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- GDPHPXYFLPDZGH-XBTMSFKCSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[2-[[(2r)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 GDPHPXYFLPDZGH-XBTMSFKCSA-N 0.000 abstract 1
- 108700029992 Ala(2)-Arg(6)- enkephalin-Leu Proteins 0.000 abstract 1
- 108010084233 deltaran Proteins 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The method for treating the acute experimental pancreatitis provides for intravenous administration of the liposomal form of Dalargin and intrabursal administration of Deltaran.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA20041209835U UA6823U (en) | 2004-12-01 | 2004-12-01 | Method for treating acute experimental pancreatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA20041209835U UA6823U (en) | 2004-12-01 | 2004-12-01 | Method for treating acute experimental pancreatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA6823U true UA6823U (en) | 2005-05-16 |
Family
ID=34883911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA20041209835U UA6823U (en) | 2004-12-01 | 2004-12-01 | Method for treating acute experimental pancreatitis |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA6823U (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008091177A1 (en) | 2007-01-18 | 2008-07-31 | Otkrytoe Aktsionernoe Obschestvo 'otechestvennye Lekarstva' | Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes |
| EP3556377A1 (en) | 2018-04-18 | 2019-10-23 | PVP Labs PTE. Ltd. | Antiviral immunotropic agent for the treatment of acute respiratory viral infections |
| EP3622964A1 (en) | 2018-09-12 | 2020-03-18 | PVP Labs PTE. Ltd. | Agent for the treatment of skin wounds or burns |
-
2004
- 2004-12-01 UA UA20041209835U patent/UA6823U/en unknown
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008091177A1 (en) | 2007-01-18 | 2008-07-31 | Otkrytoe Aktsionernoe Obschestvo 'otechestvennye Lekarstva' | Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes |
| EP3556377A1 (en) | 2018-04-18 | 2019-10-23 | PVP Labs PTE. Ltd. | Antiviral immunotropic agent for the treatment of acute respiratory viral infections |
| EP3622964A1 (en) | 2018-09-12 | 2020-03-18 | PVP Labs PTE. Ltd. | Agent for the treatment of skin wounds or burns |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL175158A0 (en) | Tocopherol-modified therapeutic drug compounds | |
| IL183963A0 (en) | 1 - aminocyclohexane - derivatives for the treatment of multiple sclerosis, emotional liability and pseudobulbar affect | |
| ZA200407813B (en) | Medicament for preventing and/or treating chronic rejection. | |
| WO2006060507A3 (en) | Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders | |
| WO2007146426A3 (en) | Nanoshells for drug delivery | |
| WO2005000213A8 (en) | Method for treating diseases using hsp90-inhibiting agents in combination with enzyme inhibitors | |
| WO2007089715A3 (en) | Method for treatment of neuropathic pain | |
| WO2008034116A3 (en) | Products and methods using soy peptides to lower total and ldl cholesterol levels | |
| EP1628667A4 (en) | Method for treating diseases using hsp90-inhibiting agents in combination with antimitotics | |
| PL373432A1 (en) | Method for treating severe heart failure and medicament therefor | |
| TW200507840A (en) | Method of treating multiple myeloma | |
| WO2006055871A3 (en) | Treatment for multiple sclerosis | |
| WO2004087066A3 (en) | Hif-1 inhibitors | |
| WO2002094189A3 (en) | Compositions and methods for treating or preventing convulsions or seizures | |
| WO2003092632A3 (en) | Cyclic peptide anti-cancer agents and methods | |
| MXPA03004566A (en) | Composite laminate for personal care product and method of making. | |
| WO2004073615A8 (en) | Deazaflavin compounds and methods of use thereof | |
| WO2008049903A3 (en) | Wide-area parasystemic treatment of skin related conditions | |
| WO2004080477A8 (en) | Aplidine for multiple myeloma treatment | |
| UA88655C2 (en) | S-mirtazapine for the treatment of hot flush | |
| UA6825U (en) | Method for treating acute experimental pancreatitis | |
| AU2001280093A1 (en) | Method for the prevention and treatment of retinopathy | |
| WO2008063853A3 (en) | Cancer treatment method | |
| UA6826U (en) | Method for treating acute experimental pancreatitis | |
| UA6829U (en) | Method for treating acute experimental pancreatitis |